Mobile app support to help people with HIV in Laos quit smoking
Implementing Sustainable mobile health Technology to Optimize smoking cessation Program for Lao people with HIV (I-STOP)
This project offers a smartphone program and clinic-based connections to help people with HIV in Laos stop smoking.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project ID | NIH-11167775 on NIH RePORTER |
What this research studies
If you have HIV and smoke, this program would offer a smartphone app that sends personalized text messages, photos, and videos to support quitting. Your clinic would also routinely ask about smoking, give brief advice, and help connect you to the app-based treatment. The study compares two ways of rolling this out across eight HIV treatment clinics in five large provinces in Laos to find the most sustainable approach. The program builds on prior work with Lao and Cambodian smokers and a clinic linkage method called Ask-Advise-Connect.
Who could benefit from this research
Good fit: Adults living with HIV in Laos who currently smoke and receive care at one of the participating ART clinics and have access to a smartphone are the ideal candidates.
Not a fit: People who do not smoke, are not receiving care at the participating clinics, or who do not have a smartphone or phone access are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, this could help more people with HIV in Laos quit smoking and reduce their cancer and other health risks.
How similar studies have performed: Previous studies show that mobile cessation programs and Ask-Advise-Connect can help people quit smoking, though combining and implementing them among people with HIV in Laos is a newer effort.
Where this research is happening
Oklahoma City, United States
- University of Oklahoma Hlth Sciences Ctr — Oklahoma City, United States (Active)
Researchers
- Principal investigator: Bui, Thanh C. — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Bui, Thanh C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.